Sun Pharma to acquire US drugmaker Organon for $11.75 billion: Here are India's biggest outgoing acquisitions
Outbound M&A deals from India reached $22 billion in 2025, led by Tata Motors and others. Sun Pharma is acquiring Organon for $11.75 billion to expand its women's health and biosimilars offerings, buying shares at a premium.
Original Source
Read the full article at Livemint →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.